换一批
换一批Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.
作者：
主题词
血管生成抑制剂(Angiogenesis Inhibitors);抗体, 单克隆(Antibodies, Monoclonal);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);结直肠肿瘤(Colorectal Neoplasms);氟尿嘧啶(Fluorouracil);人类(Humans);醛氢叶酸(Leucovorin);亚甲基四氢叶酸还原酶(NADPH)(Methylenetetrahydrofolate Reductase (NADPH2));多中心研究(主题)(Multicenter Studies as Topic);肿瘤转移(Neoplasm Metastasis);有机铂化合物(Organoplatinum Compounds);随机对照试验(主题)(Randomized Controlled Trials as Topic);存活率分析(Survival Analysis);胸苷酸合酶(Thymidylate Synthase);复合维生素B(Vitamin B Complex)
DOI
10.3816/CCC.2006.n.042
PMID
17026795
发布时间
2015-11-19
- 浏览16
Clinical colorectal cancer
229-34页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
